Literature DB >> 3755099

Growth and development two years after artificial surfactant replacement at birth.

H L Halliday, G McClure, M M Reid.   

Abstract

Two year follow-up of 80 surviving preterm babies from a controlled trial of surfactant replacement is reported. There were no statistically significant differences in rates of hospital admission, respiratory infections or antibiotic treatment. Wheezing, skin rashes and food intolerance were reported by parents with similar frequency in each group. Weight, length and occipito-frontal circumference were similar at all ages up to and including 2 years. Median developmental quotient (Griffiths scales) was 100 in the treated group and 95 in the control group (P = 0.053). Rates of cerebral palsy were similar in each group although milder forms predominated in the treated group. It is concluded that artificial surfactant (dipalmitoylphosphatidylcholine and high-density lipoprotein) replacement at birth is not associated with adverse long term effects on preterm babies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3755099     DOI: 10.1016/0378-3782(86)90067-8

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  8 in total

1.  A 2-year follow up of babies enrolled in a European multicentre trial of porcine surfactant replacement for severe neonatal respiratory distress syndrome. Collaborative European Multicentre Study Group.

Authors:  B Robertson; T Curstedt; R Tubman; D Strayer; P Berggren; J Kok; J Koppe; L van Sonderen; H Halliday; G McClure
Journal:  Eur J Pediatr       Date:  1992-05       Impact factor: 3.183

Review 2.  Bronchopulmonary dysplasia: then and now.

Authors:  W H Northway
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

Review 3.  Surfactant treatment for premature babies--a review of clinical trials.

Authors:  C J Morley
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

Review 4.  Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome.

Authors:  T A Merritt; M Hallman; R Spragg; G P Heldt; N Gilliard
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

5.  Surfactant treatment and incidence of intraventricular haemorrhage in severe respiratory distress syndrome.

Authors:  F B McCord; T Curstedt; H L Halliday; G McClure; M M Reid; B Robertson
Journal:  Arch Dis Child       Date:  1988-01       Impact factor: 3.791

6.  Automated image analysis of alveolar expansion patterns in immature newborn rabbits treated with natural or artificial surfactant.

Authors:  H Halliday; B Robertson; R Nilsson; J P Rigaut; G Grossmann
Journal:  Br J Exp Pathol       Date:  1987-10

7.  Follow up of premature babies treated with artificial surfactant (ALEC).

Authors:  C J Morley; R Morley
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

Review 8.  Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants.

Authors:  Roger Soll; Eren Ozek
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.